Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

UCD researchers discover blood test to predict response to arthritis therapies

26.09.2007
UCD researchers have shown for the first time that a simple blood test can predict those patients suffering from inflammatory arthritis who will respond to treatment at an early stage.

The group of clinicians and scientists based in UCD Conway Institute of Biomolecular & Biomedical Research and St Vincent’s University Hospital, working with collaborators from McGill University, Montreal, have published their findings in the current issue of the leading scientific journal, Arthritis and Rheumatism.

Rheumatoid arthritis and psoriatic arthritis are forms of progressive inflammatory arthritis that cause pain and progressive destruction of the joints. These diseases can be treated using drugs called tumour necrosis factor alpha (TNFa) inhibitors, which prevent damage and limit disability in arthritis patients. The extent of joint destruction can be measured by x-ray but this visible progression develops over months and years and is not suitable to measure the efficiency of treatment to reduce joint damage over a short period.

Dr Ronan Mullan, a medical PhD student with the arthritis translational research group led by Professor Douglas Veale and Dr Ursula Fearon, funded by The Health Research Board and Science Foundation Ireland, outlined the findings of this clinical study that measured particles of cartilage collagen in the blood after the start of treatment with anti-TNFa drugs. The early changes seen in the blood levels of these collagen biomarkers at 4 weeks corresponded to the visible joint destruction seen on x-ray after one year.

‘We are very excited about the results of this research, which clearly show that collagen biomarkers may be valuable early indicators of response to arthritis treatment’, said Professor Douglas Veale. ‘This new blood test could rapidly identify patients who are at risk of their disease progressing despite ongoing therapy. It would be a valuable diagnostic tool for clinicians’.

Rheumatoid arthritis is the most widespread form of inflammatory arthritis affecting more than 80,000 people in Ireland today. It can severely impact on the quality of life of patients and direct medical costs have been estimated at €30,000 per annum for each patient. An early indicator of likely response to new and expensive treatments would not only benefit the patient but the health service generally.

This research group led by Professor Douglas Veale and Dr Ursula Fearon are part of the newly formed, Dublin Academic Health Care (DAHC); Ireland’s first academic medical centre.

Elaine Quinn | alfa
Further information:
http://www.ucd.ie
http://www3.interscience.wiley.com/cgi-bin/abstract/116311017/ABSTRACT?CRETRY=1&SRETRY=0

Further reports about: Arthritis Collagen Treatment Veale destruction inflammatory

More articles from Life Sciences:

nachricht WPI team grows heart tissue on spinach leaves
23.03.2017 | Worcester Polytechnic Institute

nachricht Inactivate vaccines faster and more effectively using electron beams
23.03.2017 | Fraunhofer-Institut für Organische Elektronik, Elektronenstrahl- und Plasmatechnik FEP

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Inactivate vaccines faster and more effectively using electron beams

23.03.2017 | Life Sciences

New study maps space dust in 3-D

23.03.2017 | Physics and Astronomy

Tracing aromatic molecules in the early universe

23.03.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>